Hmf Replete (7 Sachets)

No reviews

Promotes healthy intestinal flora in adults during antibiotic use and in adults with IBS • Provides live microorganisms that are part of a healthy, natural gut flora • Probiotics to significantly reduce symptoms of irritable bowel syndrome (IBS) • Probiotics to supplement normal intestinal microbiota after antibiotic therapy • Provides 75 billion CFU per day from human-sourced probiotics: Lactobacillus acidophilus (CUL-60 & CUL-21), Bifidobacterium bifidum (CUL-20), Bifidobacterium animalis subsp. lactis (CUL-34), Lactobacillus salivarius (CUL-61) • Contains fructooligosaccharides (FOS) HMF Replete promotes healthy intestinal microflora throughout antibiotic use and in adults with IBS. The intestines contain over 400 bacterial species, and bacterial balance must be maintained for healthy intestines.1 Antibiotics alter intestinal microflora and can lead to the proliferation of antibiotic-resistant bacteria.2 Probiotics promote naturally healthy microflora and support normal intestinal microbiota after antibiotic therapy.2 IBS affects nearly 5 million Canadians and can also result from altered intestinal microflora.2,3 This leads to malabsorption of bile acids – which aid in fat digestion – and in turn, increases fluid and mucus secretion in the colon for the dilution of bile acids.2 Since lactobacilli and bifidobacteria help reabsorb bile acids, less water enters the colon, which decreases the occurrence of diarrhea.2 In a randomized placebo-controlled trial of 52 adults with IBS, daily supplementation with CUL-60, CUL-21, CUL-20, and CUL-34 significantly improved quality of life and bowel habit satisfaction scores, and decreased the number of pain days within 10 weeks.4 REFERENCES 1. Nagpal, R, Yadav, H, Kumar, M, Jain, S, Yamashiro, Y, Marotta, F. (2013). In Otles, S. (Ed.), Probiotics and Prebiotics in Food, Nutrition and Health (pp. 1-24). Boca Raton, FL: CRC Press. 2. Sarowska, J, Choroszy-Król, I, Regulska-Ilow, B, Frej-Madrzak, M, Jama-Kmiecik, A. Adv Clin Exp Med. 2013, 22(5): 759-766. 3. Fedorak, RN, Vanner, SJ, Paterson, WG, Bridges, RJ. Can J Gastroenterol. 2012, 26(5): 252-256. 4. Williams, EA, Stimpson, J, Wang, D, Plummer, S, Garaiova, I, Barker, ME, Corfe, BM. 2008, 29: 97-103.